Population‐based discovery and Mendelian randomization analysis identify telmisartan as a candidate medicine for Alzheimer's disease in African Americans-Reference-Cited by-同舟云学术

Population‐based discovery and Mendelian randomization analysis identify telmisartan as a candidate medicine for Alzheimer's disease in African Americans

Published:2022-11-04 Issue: Volume: Page:
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Zhang Pengyue¹,Hou Yuan²,Tu Wanzhu¹,Campbell Noll³,Pieper Andrew A.⁴⁵⁶⁷⁸,Leverenz James B.⁹¹⁰,Gao Sujuan¹,Cummings Jeffrey¹¹,Cheng Feixiong²⁹¹²

Affiliation:

1. Department of Biostatistics and Health Data Science Indiana University Indianapolis Indiana USA

2. Genomic Medicine Institute Lerner Research Institute Cleveland Clinic Cleveland Ohio USA

3. Department of Pharmacy Practice Purdue University West Lafayette Indiana USA

4. Harrington Discovery Institute University Hospitals Cleveland Medical Center Cleveland Ohio USA

5. Department of Psychiatry Case Western Reserve University Cleveland Ohio USA

6. Geriatric Psychiatry GRECC Louis Stokes Cleveland VA Medical Center Cleveland Ohio USA

7. Institute for Transformative Molecular Medicine School of Medicine Case Western Reserve University Cleveland Ohio USA

8. Department of Neuroscience Case Western Reserve University School of Medicine Cleveland Ohio USA

9. Department of Molecular Medicine Cleveland Clinic Lerner College of Medicine Case Western Reserve University Cleveland Ohio USA

10. Lou Ruvo Center for Brain Health Neurological Institute Cleveland Clinic Cleveland Ohio USA

11. Chambers‐Grundy Center for Transformative Neuroscience Department of Brain Health School of Integrated Health Sciences University of Nevada Las Vegas Las Vegas Nevada USA

12. Case Comprehensive Cancer Center Case Western Reserve University School of Medicine Cleveland Ohio USA

Funder

National Institute on Aging

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12819

Reference78 articles.

1. The discovery of Alzheimer's disease

2. Asher Mullard.Controversial Alzheimer's drug approval could affect other diseases.2021;2021.

3. Current and Future Treatments in Alzheimer Disease: An Update

4. 2021 Alzheimer's disease facts and figures

5. Trends in Relative Incidence and Prevalence of Dementia Across Non-Hispanic Black and White Individuals in the United States, 2000-2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex-stratified genome-wide association and transcriptome-wide Mendelian randomization studies reveal drug targets of heart failure;Cell Reports Medicine;2024-01

2. RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one;Revista Portuguesa de Cardiologia;2023-11

3. Disentangling in-vivo microstructural changes of white and gray matter in mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis;Brain Imaging and Behavior;2023-09-27

4. Investigating the Impact of Selective Modulators on the Renin–Angiotensin–Aldosterone System: Unraveling Their Off-Target Perturbations of Transmembrane Ionic Currents;International Journal of Molecular Sciences;2023-09-12

5. Therapeutic Implications of Renin–Angiotensin System Modulators in Alzheimer’s Dementia;Pharmaceutics;2023-09-06